CG MedTech's Q3 Operating Profit Rises 204%... Revenue Grows 64%
Third-quarter revenue of KRW 18.6 billion and operating profit of KRW 3 billion... Operating margin at 16%
DM Power revenue more than tripled... Operating profit of KRW 1.2 billion, turning profitable
CG MedTech, a medical device company, said on Nov. 16 that its consolidated revenue and operating profit both increased in the third quarter of this year, driven by growth in its core business and improved results at its subsidiaries.
CG MedTech's consolidated revenue in the third quarter was KRW 18.6 billion, and operating profit was KRW 3 billion, up 64% and 204%, respectively, from the same period a year earlier. Its operating margin rose to 16%, up 7 percentage points from 9% in the same period last year.
Cumulative revenue from January through September was KRW 46.9 billion, up 31% from the same period last year. Cumulative operating profit rose 3% to KRW 3.6 billion. Cumulative revenue was equivalent to 99% of last year's record annual revenue of KRW 47.2 billion, raising expectations that the company will set a new annual revenue record this year.
Growth continued on a non-consolidated basis as well. CG MedTech's cumulative revenue from January through September was KRW 26.1 billion, up 26% from the same period last year. Overseas revenue increased 23% to KRW 12.1 billion. Expanded supply of implant prosthetic products and growth in its spine and orthopedic medical device businesses supported its performance.
Improved results at subsidiary DM Power also contributed to the increase in consolidated results. DM Power's third-quarter revenue was KRW 6.8 billion, more than three times the KRW 2.2 billion recorded in the same period last year. It posted an operating profit of KRW 1.2 billion, turning profitable.
From January through September, its cumulative revenue reached KRW 14.1 billion and operating profit reached KRW 1.9 billion, surpassing its full-year results last year of KRW 12.2 billion in revenue and KRW 900 million in operating profit. The results reflect sales from orders secured for Korea Electric Power Corporation's next-generation electricity meter project, AMIGO.
All Abutment, a dental-related subsidiary, also improved its profitability, with its third-quarter operating profit increasing from the same period last year.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Yoo Hyunseung, CEO of CG MedTech, said, "These results were achieved through growth in our core business and improved performance at key subsidiaries. We expect new businesses, including ECM skin boosters, to begin making a meaningful contribution to revenue starting in the fourth quarter." He added, "We will accelerate the expansion of new revenue based on our ADM CDMO supply agreement with Kolon Pharmaceutical and our collaboration with Liv Science on the ECM business."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.